Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
Clinical trial NCT05958134 · COMPLETED
Trial details
- NCT number
- NCT05958134
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-15
- Primary completion
- 2024-06-06
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.